Perbedaan Ciputra Development Tbk dan Diagnos Laboratorium Utama Tbk.: Ciputra Development Tbk diperdagangkan di Rp595 (kapitalisasi pasar 11,31 T, volume 24 jam 3,92 jt), sedangkan Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp234 (kapitalisasi pasar 316,25 M, volume 24 jam 20,9 rb). Perbedaan utamanya: Ciputra Development Tbk jauh lebih besar — sekitar 35,8× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Ciputra Development Tbk lebih aktif diperdagangkan (3,92 jt vs 20,9 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CTRA | DGNS | |
|---|---|---|
Kapitalisasi Pasar | 11,31 T | 316,25 M |
Volume | 3,92 jt | 20,9 rb |
Lot | 39,22 rb | 209 |
Perputaran | 2,35 M | 4,83 jt |
Harga Rata-rata | 599,64 | 231,06 |
Nilai Transaksi | 2,35 M | 4,83 jt |
Harga Ekuilibrium Indikatif | 605 | 230 |
Volume Ekuilibrium Indikatif | 1,26 rb | 2,4 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Selengkapnya di halaman CTRA →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →